Thermodynamic and Structure Guided Design of Statin Based Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase

DOCK 6: Impact of new features and current docking performance

Allen, W. J., Balius, T. E., Mukherjee, S., Brozell, S. R., Moustakas, D. T., Lang, P. T., Case, D. A., Kuntz, I. D., & Rizzo, R. C. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.23905 · Cited by 870

The modification of natural products for medical use

Guo, Z. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.06.003 · Cited by 340

High-precision, automated integration of multiple isothermal titration calorimetric thermograms: New features of NITPIC

Scheuermann, T. H., & Brautigam, C. A. (2014) · Methods · doi:10.1016/j.ymeth.2014.11.024 · Cited by 224

Target–drug interactions: first principles and their application to drug discovery

Núñez, S., Venhorst, J., & Kruse, C. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.013 · Cited by 187

A Thermodynamic Approach to the Affinity Optimization of Drug Candidates

Freire, E. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00880.x · Cited by 146

Thermodynamics guided lead discovery and optimization

Ferenczy, G. G., & Keserű, G. M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.013 · Cited by 139

Statins in therapy: Understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies

Fong, C. W. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.037 · Cited by 136

Exploration of Potentially Bioactive Peptides Generated from the Enzymatic Hydrolysis of Hempseed Proteins

Aiello, G., Lammi, C., Boschin, G., Zanoni, C., & Arnoldi, A. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03590 · Cited by 101

An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia

Gesto, D., Pereira, C. M. S. B., Cerqueira, N. M. F. S. A., & Sousa, S. F. (2020) · Molecules · doi:10.3390/molecules25173891 · Cited by 100

Natural Products in Medicine: Transformational Outcome of Synthetic Chemistry

Szychowski, J., Truchon, J., & Bennani, Y. L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500941m · Cited by 96

Two Peptides from Soy β-Conglycinin Induce a Hypocholesterolemic Effect in HepG2 Cells by a Statin-Like Mechanism: Comparative in Vitro and in Silico Modeling Studies

Lammi, C., Zanoni, C., Arnoldi, A., & Vistoli, G. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b03497 · Cited by 89

Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase

Cuccioloni, M., Mozzicafreddo, M., Spina, M., Tran, C. N., Falconi, M., Eleuteri, A. M., & Angeletti, M. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011817 · Cited by 88

Long Non-coding RNAs Expression Profile in HepG2 Cells Reveals the Potential Role of Long Non-coding RNAs in the Cholesterol Metabolism

Liu, G., Zheng, X., Xu, Y.-L., Lü, J., Chen, J., & Huang, X. (2014) · Chinese Medical Journal · doi:10.4103/0366-6999.147824 · Cited by 63

Altered Enthalpy−Entropy Compensation in Picomolar Transition State Analogues of Human Purine Nucleoside Phosphorylase

Edwards, A. A., Mason, J. M., Clinch, K., Tyler, P. C., Evans, G. B., & Schramm, V. L. (2009) · Biochemistry · doi:10.1021/bi9005896 · Cited by 59

Some Binding-Related Drug Properties are Dependent on Thermodynamic Signature

Schön, A., Madani, N., Smith, A. B., LaLonde, J. M., & Freire, E. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.01075.x · Cited by 48

Is there a link between selectivity and binding thermodynamics profiles?

Tarcsay, Á., & Keserű, G. M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.014 · Cited by 47

Bioactivities of Centaurium erythraea (Gentianaceae) Decoctions: Antioxidant Activity, Enzyme Inhibition and Docking Studies

Guedes, L., Reis, P. B. P. S., Machuqueiro, M., Ressaissi, A., Pacheco, R., & Serralheiro, M. L. (2019) · Molecules · doi:10.3390/molecules24203795 · Cited by 44

Do structural differences in statins correlate with clinical efficacy?

Arnaboldi, L., & Corsini, A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833b776c · Cited by 35

DOX: A new computational protocol for accurate prediction of the protein–ligand binding structures

Rao, L., Chi, B., Ren, Y., Li, Y., Xu, X., & Wan, J. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.24217 · Cited by 32

Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations

Son, M., Baek, A., Sakkiah, S., Park, C., John, S., & Lee, K. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083496 · Cited by 30

Chemical structure modifications and nano‐technology applications for improving ADME‐Tox properties, a review

Farouk, F., & Shamma, R. N. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201800213 · Cited by 28

Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins

Perchellet (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000274 · Cited by 28

A fungal tolerance trait and selective inhibitors proffer HMG-CoA reductase as a herbicide mode-of-action

Haywood, J., Breese, K. J., Zhang, J., Waters, M. T., Bond, C. S., Stubbs, K. A., & Mylne, J. S. (2022) · Nature Communications · doi:10.1038/s41467-022-33185-0 · Cited by 27

In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans

Mahmoud, D. E., Faraag, A. H. I., & Abu El-Wafa, W. M. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03158-4 · Cited by 26

Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects

Huang, Y., Wei, L., Han, X., Chen, H., Ren, Y., Xu, Y., Song, R., Rao, L., Chen, S., Peng, C., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111749 · Cited by 24

Synthesis of 3,4-fused cycloalkanopyrroles by 1,3-dipolar cycloaddition

Kelly, J. M., & Leeper, F. J. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.12.013 · Cited by 24

Targeting prenylation inhibition through the mevalonate pathway

Manaswiyoungkul, P., de Araujo, E. D., & Gunning, P. T. (2019) · RSC Medicinal Chemistry · doi:10.1039/c9md00442d · Cited by 22

Structure-Based Design and Screen of Novel Inhibitors for Class II 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase from Streptococcus Pneumoniae

Li, D., Gui, J., Li, Y., Feng, L., Han, X., Sun, Y., Sun, T., Chen, Z., Cao, Y., Zhang, Y., et al. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300163v · Cited by 20

Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity

Lammi, C., Fassi, E. M. A., Li, J., Bartolomei, M., Benigno, G., Roda, G., Arnoldi, A., & Grazioso, G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030665 · Cited by 18

A ruthenium derivative of quercetin with enhanced cholesterol-lowering activity

Cuccioloni, M., Bonfili, L., Mozzicafreddo, M., Cecarini, V., Pettinari, R., Condello, F., Pettinari, C., Marchetti, F., Angeletti, M., & Eleuteri, A. M. (2016) · RSC Advances · doi:10.1039/c6ra06403e · Cited by 17

Synthesis and antihyperlipidemic efficiency of berberine-based HMG-CoA reductase inhibitor

Ye, X., He, K., Zhu, X., Zhang, B., Chen, X., Yi, J., & Li, X. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9651-z · Cited by 15

Preparation, characterization and in vitro release of microparticles based on dextran–rosuvastatin conjugate

Zhou, C., Gao, W., Lu, G., Ding, J., Wu, X., Huang, X., Chen, J., Liu, M., Jiang, J., & Wu, H. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.03.094 · Cited by 15

A molecular modeling approach for structure-based virtual screening and identification of novel anti-hypercholesterolemic agents from Grape

Akinnusi, P. A., Olubode, S. O., Alade, A. A., Ahmed, S. A., Ayekolu, S. F., Ogunlade, T. M., Gbore, D. J., Rotimi, O. D., & Ayodele, A. O. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.101065 · Cited by 14

Inhibition of fat accumulation, lipid dysmetabolism, cardiac inflammation, and improved nitric oxide signalling mediate the protective effects of lycopene against cardio-metabolic disorder in obese female rats

Ugwor, E. I., Ugbaja, R. N., James, A. S., Dosumu, O. A., Thomas, F. C., Ezenandu, E. O., & Graham, R. E. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.05.009 · Cited by 14

Role of Panax ginseng and ginsenosides in regulating cholesterol homeostasis

Cecarini, V., Cuccioloni, M., Gong, C., Liu, Z., Bonfili, L., Angeletti, M., Angeloni, S., Alessandroni, L., Sagratini, G., Liu, H., et al. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103256 · Cited by 13

Determination of binding affinities of 3-Hydroxy-3-Methylglutaryl Coenzyme A reductase inhibitors from free energy calculation

Sun, Z., Wang, X., & Zhang, J. Z. H. (2019) · Chemical Physics Letters · doi:10.1016/j.cplett.2019.03.020 · Cited by 12

Pharmacophore Modeling and Binding Affinity of Secondary Metabolites from Angelica keiskei to HMG Co-A Reductase

Aulifa, D. L., Amirah, S. R., Rahayu, D., Megantara, S., & Muchtaridi, M. (2024) · Molecules · doi:10.3390/molecules29132983 · Cited by 10

Rank Order Entropy: Why One Metric Is Not Enough

McLellan, M. R., Ryan, M., & Breneman, C. M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200170k · Cited by 10

The Binding Thermodynamics of Drug Candidates

Freire, E. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673025.ch1 · Cited by 9

Current Advances in the Synthesis and Biological Evaluation of Pharmacologically Relevant 1,2,4,5-Tetrasubstituted-1H-Imidazole Derivatives

Rossi, R., & Ciofalo, M. (2019) · Current Organic Chemistry · doi:10.2174/1385272823666191014154129 · Cited by 8

Proteomics research of SARS-CoV-2 and COVID-19 disease

Zhang, N., Wang, S., & Wong, C. C. L. (2022) · Medical Review · doi:10.1515/mr-2022-0016 · Cited by 7

Medicinal chemistry and pharmacology of statins

Moore, B. M., II, & Cook, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00012-2 · Cited by 6

The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

Gülcan, H. O., Yiğitkan, S., & Orhan, İ. E. (2018) · Letters in Drug Design & Discovery · doi:10.2174/1570180816666181112144353 · Cited by 6

Synthesis of 1,3,5‐Trisubstituted [4‐tert‐Butyl 2‐(5,5‐difluoro‐2,2‐dimethyl‐6‐vinyl‐1,3‐dioxan‐4‐yl)acetate]pyrazoles via a Pd‐Catalyzed CH Activation

Wang, X., Fang, X. M., Yang, X., Ni, M., & Wu, F. (2012) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201201100 · Cited by 6

Recent Progress in the Synthesis of Super-Statins

Časar, Z. (2015) · Topics in heterocyclic chemistry · doi:10.1007/7081_2015_189 · Cited by 6

Screening of HMG-CoA Reductase Inhibitors from Composite Salvia Miltiorrhiza Using Autodock

Gai, W., Zhang, Y., Ai, L., & Qiao, Y. (2010) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(10)60006-4 · Cited by 5

Rationalization of the Performance and Target Dependence of Similarity Searching Incorporating Protein−Ligand Interaction Information

Tan, L., Batista, J., & Bajorath, J. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci1001197 · Cited by 4

Hypolipidemic Activity of Sesquiterpene Lactones and their Derivatives

Adekenov, S. M., Mareška, V., Ivanov, V. V., Maslova, O. V., Doskaliyev, A., Shaidarov, M., & Spiwok, V. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11650 · Cited by 2

Stability-Driven Pose Prediction and Ligand Design via Contact Persistence Analysis from Molecular Dynamics Simulations

Nasution, M. A. F., Bekker, G., Re, S., & Mizuguchi, K. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0093 · Cited by 2

Some Practical Rules for the Thermodynamic Optimization of Drug Candidates

Freire, E. (2012) · Wiley eBooks · doi:10.1002/9783527645947.ch2 · Cited by 2

Combining classical molecular docking with self-consistent charge density-functional tight-binding computations for the efficient and quality prediction of ligand binding structure

Al-Ansi, A. Y., Lu, H., & Lin, Z. (2022) · Journal of Chemical Research · doi:10.1177/17475198221101999 · Cited by 2

Solvation Energetic Costs of Cognate Binding Site Formation

Ji, Y., Molino, V., Ramsey, S., & Kurtzman, T. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01432 · Cited by 1

A Novel HMG-CoA Reductase Inhibitor from Methanolic Extract of Holoptelea integrifolia (Roxb.) Planch

Arun, K., & Augustine, A. (2012) · Springer eBooks · doi:10.1007/978-81-322-0810-5_7

Thermodynamics in Lead Optimization

Holdgate, G. A., Scott, A., & Davies, G. M. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673025.ch6

Lanosterol biosynthesis pathway (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Benson, H. E. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f104/2019.4

Mechanisms of Semen Cassiae to Treat Hypercholesterolemia Based on Molecular Docking

Ye, Q. (2022) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2022.12.06

Lanosterol biosynthesis pathway in GtoPdb v.2023.1

Benson, H. E. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f104/2023.1

Quantum Mechanics-Based Fast and Reliable Prediction of Binding Pose Structures

Al-Ansi, A. Y., Al-Shawesh, G. H., Ru, X., & Lin, Z. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c02596

Cholesterol-lowering drug atorvastatin

Huang, Z., Tan, J.-H., & Chen, S.-B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27402-2.00033-4

Solvation Thermodynamic Costs of Cognate Binding Site FormationPreprint

Ji, Y., Molino, V., Ramsey, S., & Kurtzman, T. (2025) · ChemRxiv · doi:10.26434/chemrxiv-2024-hdk1p-v3

Unlocking the potential of Citrullus ecirrhosus Cogn seed for antioxidant and HMG-CoA reductase improvement in silico

Kambasiya, W., Bakwali, M., Lekutlane, D., Gaaipone, M. T., Lotshwao, B., Makopa, T. P., Li, C., Gaobotse, G., Makhzoum, A. B., & Masisi, K. (2025) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2025.2603145

Mechanistic insights into the cholesterol-lowering activity of γ-oryzanol components

Cuccioloni, M., Juricic, H., Bonfili, L., Liu, Z., Abate, G., Uberti, D. L., Angeletti, M., Eleuteri, A. M., & Cecarini, V. (2026) · Food & Function · doi:10.1039/d5fo03394b

The key technology in drug discovery: structural modification of natural products

Wang, C., Wang, J., & Li, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40578-5.00012-x

Vers un potentiel multipolaire quantitatif et transférable aux macromolécules biologiques : une étude méthodologique des effets de la polarisabilité

Leduc, T. (2019) · theses.fr (ABES) · doi:10.70675/1a2bb49ez8fafz4ec2z9297zfba19b9feb1a

BindingDB Entry 50006895: Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.

BindingDB (2021) · UC San Diego · doi:10.7270/q2rb77w3

BindingDB Entry 5732: Altered enthalpy-entropy compensation in picomolar transition state analogues of human purine nucleoside phosphorylase.

BindingDB (2013) · UC San Diego · doi:10.7270/q2sb44c9

Agnuside from Vitex negundo L. Attenuates Hepatocellular Lipid Accumulation: Association with the AMPK/SREBP1/FASN/HMGCR/PPARα/UCP2 Signaling Network

Saikia, A., Ahmed, S. A., Saikia, K., Sarma, P., Basumatary, D., Mukherjee, A. K., Borah, J. C., & Bala, A. (2026) · ACS Omega · doi:10.1021/acsomega.6c06583

Conserved recognition and divergent peripheral dynamics of designed statin analogues at human HMG-CoA reductase: ensemble docking and replicated molecular dynamicsPreprint

Towle, T. (2026) · ChemRxiv · doi:10.26434/chemrxiv.15011586/v1

Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase

Istvan, E. S. (2002) · American Heart Journal · doi:10.1067/mhj.2002.130300 · Cited by 142

Structural mechanism for statin inhibition of HMG-CoA reductase

Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644

Structure-Based Rational Quest for Potential Novel Inhibitors of Human HMG-CoA Reductase by Combining CoMFA 3D QSAR Modeling and Virtual Screening

Zhang, Q. Y., Wan, J., Xu, X., Yang, G., Ren, Y. L., Liu, J., Wang, H., & Guo, Y. (2006) · Journal of Combinatorial Chemistry · doi:10.1021/cc060101e · Cited by 32

Binding Thermodynamics of Statins to HMG-CoA Reductase

Carbonell, T., & Freire, E. (2005) · Biochemistry · doi:10.1021/bi050905v · Cited by 103

Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA)

Thilagavathi, R., Kumar, R., Vema, A., Sobhia, M. E., Bulusu, G., & Chakraborti, A. K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.042 · Cited by 14